Cargando…

Deletion of the Ste20-like kinase SLK in skeletal muscle results in a progressive myopathy and muscle weakness

BACKGROUND: The Ste20-like kinase, SLK, plays an important role in cell proliferation and cytoskeletal remodeling. In fibroblasts, SLK has been shown to respond to FAK/Src signaling and regulate focal adhesion turnover through Paxillin phosphorylation. Full-length SLK has also been shown to be essen...

Descripción completa

Detalles Bibliográficos
Autores principales: Pryce, Benjamin R., Al-Zahrani, Khalid N., Dufresne, Sébastien, Belkina, Natalya, Labrèche, Cédrik, Patino-Lopez, Genaro, Frenette, Jérôme, Shaw, Stephen, Sabourin, Luc A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288853/
https://www.ncbi.nlm.nih.gov/pubmed/28153048
http://dx.doi.org/10.1186/s13395-016-0119-1
_version_ 1782504403159220224
author Pryce, Benjamin R.
Al-Zahrani, Khalid N.
Dufresne, Sébastien
Belkina, Natalya
Labrèche, Cédrik
Patino-Lopez, Genaro
Frenette, Jérôme
Shaw, Stephen
Sabourin, Luc A.
author_facet Pryce, Benjamin R.
Al-Zahrani, Khalid N.
Dufresne, Sébastien
Belkina, Natalya
Labrèche, Cédrik
Patino-Lopez, Genaro
Frenette, Jérôme
Shaw, Stephen
Sabourin, Luc A.
author_sort Pryce, Benjamin R.
collection PubMed
description BACKGROUND: The Ste20-like kinase, SLK, plays an important role in cell proliferation and cytoskeletal remodeling. In fibroblasts, SLK has been shown to respond to FAK/Src signaling and regulate focal adhesion turnover through Paxillin phosphorylation. Full-length SLK has also been shown to be essential for embryonic development. In myoblasts, the overexpression of a dominant negative SLK is sufficient to block myoblast fusion. METHODS: In this study, we crossed the Myf5-Cre mouse model with our conditional SLK knockout model to delete SLK in skeletal muscle. A thorough analysis of skeletal muscle tissue was undertaken in order to identify defects in muscle development caused by the lack of SLK. Isometric force analysis was performed on adult knockout mice and compared to age-matched wild-type mice. Furthermore, cardiotoxin injections were performed followed by immunohistochemistry for myogenic markers to assess the efficiency muscle regeneration following SLK deletion. RESULTS: We show here that early deletion of SLK from the myogenic lineage does not markedly impair skeletal muscle development but delays the regenerative process. Interestingly, adult mice (~6 months) display an increase in the proportion of central nuclei and increased p38 activation. Furthermore, mice as young as 3 months old present with decreased force generation, suggesting that the loss of SLK impairs myofiber stability and function. Assessment of structural components revealed aberrant localization of focal adhesion proteins, such as FAK and paxillin. Our data show that the loss of SLK results in unstable myofibers resulting in a progressive myopathy. Additionally, the loss of SLK resulted in a delay in muscle regeneration following cardiotoxin injections. CONCLUSIONS: Our results show that SLK is dispensable for muscle development and regeneration but is required for myofiber stability and optimal force generation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13395-016-0119-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5288853
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52888532017-02-06 Deletion of the Ste20-like kinase SLK in skeletal muscle results in a progressive myopathy and muscle weakness Pryce, Benjamin R. Al-Zahrani, Khalid N. Dufresne, Sébastien Belkina, Natalya Labrèche, Cédrik Patino-Lopez, Genaro Frenette, Jérôme Shaw, Stephen Sabourin, Luc A. Skelet Muscle Research BACKGROUND: The Ste20-like kinase, SLK, plays an important role in cell proliferation and cytoskeletal remodeling. In fibroblasts, SLK has been shown to respond to FAK/Src signaling and regulate focal adhesion turnover through Paxillin phosphorylation. Full-length SLK has also been shown to be essential for embryonic development. In myoblasts, the overexpression of a dominant negative SLK is sufficient to block myoblast fusion. METHODS: In this study, we crossed the Myf5-Cre mouse model with our conditional SLK knockout model to delete SLK in skeletal muscle. A thorough analysis of skeletal muscle tissue was undertaken in order to identify defects in muscle development caused by the lack of SLK. Isometric force analysis was performed on adult knockout mice and compared to age-matched wild-type mice. Furthermore, cardiotoxin injections were performed followed by immunohistochemistry for myogenic markers to assess the efficiency muscle regeneration following SLK deletion. RESULTS: We show here that early deletion of SLK from the myogenic lineage does not markedly impair skeletal muscle development but delays the regenerative process. Interestingly, adult mice (~6 months) display an increase in the proportion of central nuclei and increased p38 activation. Furthermore, mice as young as 3 months old present with decreased force generation, suggesting that the loss of SLK impairs myofiber stability and function. Assessment of structural components revealed aberrant localization of focal adhesion proteins, such as FAK and paxillin. Our data show that the loss of SLK results in unstable myofibers resulting in a progressive myopathy. Additionally, the loss of SLK resulted in a delay in muscle regeneration following cardiotoxin injections. CONCLUSIONS: Our results show that SLK is dispensable for muscle development and regeneration but is required for myofiber stability and optimal force generation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13395-016-0119-1) contains supplementary material, which is available to authorized users. BioMed Central 2017-02-02 /pmc/articles/PMC5288853/ /pubmed/28153048 http://dx.doi.org/10.1186/s13395-016-0119-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Pryce, Benjamin R.
Al-Zahrani, Khalid N.
Dufresne, Sébastien
Belkina, Natalya
Labrèche, Cédrik
Patino-Lopez, Genaro
Frenette, Jérôme
Shaw, Stephen
Sabourin, Luc A.
Deletion of the Ste20-like kinase SLK in skeletal muscle results in a progressive myopathy and muscle weakness
title Deletion of the Ste20-like kinase SLK in skeletal muscle results in a progressive myopathy and muscle weakness
title_full Deletion of the Ste20-like kinase SLK in skeletal muscle results in a progressive myopathy and muscle weakness
title_fullStr Deletion of the Ste20-like kinase SLK in skeletal muscle results in a progressive myopathy and muscle weakness
title_full_unstemmed Deletion of the Ste20-like kinase SLK in skeletal muscle results in a progressive myopathy and muscle weakness
title_short Deletion of the Ste20-like kinase SLK in skeletal muscle results in a progressive myopathy and muscle weakness
title_sort deletion of the ste20-like kinase slk in skeletal muscle results in a progressive myopathy and muscle weakness
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288853/
https://www.ncbi.nlm.nih.gov/pubmed/28153048
http://dx.doi.org/10.1186/s13395-016-0119-1
work_keys_str_mv AT prycebenjaminr deletionoftheste20likekinaseslkinskeletalmuscleresultsinaprogressivemyopathyandmuscleweakness
AT alzahranikhalidn deletionoftheste20likekinaseslkinskeletalmuscleresultsinaprogressivemyopathyandmuscleweakness
AT dufresnesebastien deletionoftheste20likekinaseslkinskeletalmuscleresultsinaprogressivemyopathyandmuscleweakness
AT belkinanatalya deletionoftheste20likekinaseslkinskeletalmuscleresultsinaprogressivemyopathyandmuscleweakness
AT labrechecedrik deletionoftheste20likekinaseslkinskeletalmuscleresultsinaprogressivemyopathyandmuscleweakness
AT patinolopezgenaro deletionoftheste20likekinaseslkinskeletalmuscleresultsinaprogressivemyopathyandmuscleweakness
AT frenettejerome deletionoftheste20likekinaseslkinskeletalmuscleresultsinaprogressivemyopathyandmuscleweakness
AT shawstephen deletionoftheste20likekinaseslkinskeletalmuscleresultsinaprogressivemyopathyandmuscleweakness
AT sabourinluca deletionoftheste20likekinaseslkinskeletalmuscleresultsinaprogressivemyopathyandmuscleweakness